Mayo Clinic Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Predible HealthinDec 2020acquired by nference · May 2022
nference partners with medical centers to extract and synthesize biomedical data from electronic medical records, enabling drug discovery and personalized medicine development.
AI & Machine LearningBiotechDigital HealthHealthtechCambridge, US
Murali Aravamudan(CEO)Venky Soundararajan(Chief Scientific Officer)
Co-investorsCapria VenturesMatrixMatrix Capital Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.